C1 Inhibitor (Human) (Haegarda) and Lixisenatide Subcutaneous
Determining the interaction of C1 Inhibitor (Human) (Haegarda) and Lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: C1 esterase inhibitor (human)
Brand name: Berinert, Cinryze, Haegarda, Ruconest
Synonyms: Complement C1 esterase inhibitor, C1 Inhibitor (Human)
Generic Name: lixisenatide
Brand name: Adlyxin
Synonyms: Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- C1 Inhibitor (Human) (Haegarda)-Lixtraxen Injection
- C1 Inhibitor (Human) (Haegarda)-LMD
- C1 Inhibitor (Human) (Haegarda)-LMD Injection
- C1 Inhibitor (Human) (Haegarda)-LMX 4 Topical application
- C1 Inhibitor (Human) (Haegarda)-LMX 5
- C1 Inhibitor (Human) (Haegarda)-LMX 5 Topical application
- Lixisenatide Subcutaneous-C1 Inhibitor (Recombinant)
- Lixisenatide Subcutaneous-C1-Esterase Inhibitor (Human)
- Lixisenatide Subcutaneous-C1-Esterase Inhibitor (Recombinant)
- Lixisenatide Subcutaneous-Cabazitaxel
- Lixisenatide Subcutaneous-Cabazitaxel Intravenous
- Lixisenatide Subcutaneous-Cabergoline